Central Trust Company’s iShares US Medical Devices ETF IHI Stock Holding History

Central Trust Company’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-261	Closed	-$15.7K	–	1460
2025 Q1	$15.7K	Hold	261	–	–	﹤0.01%	1015
2024 Q4	$15.2K	Hold	261	–	–	﹤0.01%	1025
2024 Q3	$15.5K	Hold	261	–	–	﹤0.01%	995
2024 Q2	$14.6K	Hold	261	–	–	﹤0.01%	999
2024 Q1	$15.3K	Hold	261	–	–	﹤0.01%	1007
2023 Q4	$14.1K	Sell	261 -114	-30%	-$5.57K	﹤0.01%	1016
2023 Q3	$18.2K	Hold	375	–	–	﹤0.01%	948
2023 Q2	$21.2K	Hold	375	–	–	﹤0.01%	921
2023 Q1	$20.2K	Buy	+375	New	+$20K	﹤0.01%	939
2020 Q2	–	Sell	-1,200	Closed	-$45K	–	1100
2020 Q1	$45K	Sell	1,200 -300	-20%	-$12.6K	﹤0.01%	627
2019 Q4	$66K	Hold	1,500	–	–	﹤0.01%	633
2019 Q3	$62K	Hold	1,500	–	–	﹤0.01%	613
2019 Q2	$61K	Hold	1,500	–	–	﹤0.01%	618
2019 Q1	$58K	Hold	1,500	–	–	﹤0.01%	608
2018 Q4	$50K	Hold	1,500	–	–	﹤0.01%	636
2018 Q3	$57K	Buy	+1,500	New	+$53.3K	﹤0.01%	657

Other funds holding IHI

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Central Trust Company's IHI Position: Q2 2025 in Review

Central Trust Company sold out of iShares US Medical Devices ETF (IHI) in Q2 2025, closing a stake of 261 shares — an estimated $15.7K sold.

Central Trust Company first reported a position in IHI in Q3 2018 and held it in 16 quarters. The position peaked at $66K in Q4 2019. 547 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

Central Trust Company reported no remaining iShares US Medical Devices ETF position as of Q2 2025 after selling out during the quarter.
Central Trust Company sold 261 iShares US Medical Devices ETF shares in Q2 2025, an estimated $15.7K.
Central Trust Company first reported a position in iShares US Medical Devices ETF in Q3 2018 and held it in 16 quarters.
Central Trust Company's iShares US Medical Devices ETF position peaked at $66K in Q4 2019.
547 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on Central Trust Company's 13F filing for Q2 2025, filed 7 Aug 2025.